Medrx Infusion
Medrx Infusion is the expert in infusion therapy and specialty pharmacy services. Whether you’re a patient receiving IVIG infusion at home or a provider referring patients, Medrx Infusion delivers personalized care and access to specialty medications.
- Indexed episodes, last 90 days
- 3
- Latest publication
- Aug 26, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 14, 2026
Latest episodes
3 Benefits of Getting IVIG Infusions at Home (opens the original)
Read excerpt
If you need more support in managing a condition, your healthcare provider may refer you to an at-home IV infusion company offering intravenous immunoglobulin (IVIG) therapy. IVIG infusion therapy is a way to support your body with additional white blood cells, usually administered with a catheter and a saline solution. While you can receive this kind of treatment in-office, there are many benefits to receiving IVIG therapy at home. Discover IVIG home infusion services with Medrx Infusion at htt
3 Reasons to Consider IVIG as a Secondary Treatment (opens the original)
Read excerpt
Intravenous immunoglobulin, or IVIG, is often prescribed as a secondary treatment for several indications, including secondary immunodeficiency (SID). Is it right for you? If so, you might consider IVIG treatment and therapy at home. If IVIG isn’t quite right, a subcutaneous infusion might be right for you. Here is what you need to know about IVIG and whether a secondary treatment is right for you. Learn more about IVIG as a secondary treatment and how you can have it at home at https://medrxinf
3 Reasons to Consider IVIG as a Secondary Treatment (opens the original)
Read excerpt
Intravenous immunoglobulin, or IVIG, is often prescribed as a secondary treatment for several indications, including secondary immunodeficiency (SID). Is it right for you? If so, you might consider IVIG treatment and therapy at home. If IVIG isn’t quite right, a subcutaneous infusion might be right for you. Here is what you need to know about IVIG and whether a secondary treatment is right for you.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.